ArticleAmerican journal of translational research2026
Affordable care act and 4-year all-cause mortality among U.S. working-age adults with or without cancer: 2000-2015.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt is unclear how associations of socioeconomic and behavioral factors with mortality in U.S. working-age adults with cancer changed after implementing the Affordable Care Act (ACA). Therefore, we examined changes in associations of prognostic factors with 4-year mortality risk in working-age American adults after implementing the ACA by cancer status.
methodsWe conducted 4 retrospective cohort studies, using the National Health Interview Survey data from 2000 to 2015, linked to the National Death Index through December 2019. The primary outcome was 4-year all-cause mortality. Multivariable logistic regression was used to quantify the associations of various factors with 4-year mortality in each cohort for all, cancer and non-cancer participants. Difference-in-difference analyses were performed to compare adjusted odds ratios (aOR) before and after the ACA implementation.
resultsThe 4 retrospective cohort studies included ~307 million U.S. working-age adults (aged 18-64 years, with 74-78 million weighted participants in each cohort) who participated in the survey years 2000, 2005, 2010, and 2015. Cancer prevalence among U.S. working-age adults rose 13.0% (5,150 per 100,000 in the 2015 cohort versus 3,970 per 100,000 in the 2000 cohort). Difference-in-difference analyses showed aORs of cancer, sex, age, race, and smoking-status for 4-year all-cause mortality risk remained unchanged throughout the 15 years. However, post-ACA regional gaps widened among cancer patients, with increasing aORs in the South and West versus the Northeast region. Post-ACA age-gaps reduced among non-cancer participants, with decreasing aORs in participants aged 55-64 or 45-54 years (versus 18-34 years).
conclusionsCancer prevalence among U.S. working-age adults rose significantly during 2000-2015. There were no significant post-ACA changes in associations of key prognostic factors with 4-year mortality in all participants. However, the influences of ACA implementation on socioeconomic disparities differed by cancer status. Further works should focus on its influence by other disease status, including diabetes and cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.